|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.940 USD | -1.00% |
|
-15.14% | -49.01% |
| 07-17 | Ars Pharmaceuticals, Inc. Announces Management Changes, Effective July 15, 2026 | CI |
| 07-07 | ARS Pharmaceuticals, Inc. Announces Appointment of Donn Casale as Director, Effective July 7, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 7.94 | 7.94 | 8.56 |
| Spread/Res. | -25.19% | -25.19% | -30.61% |
| Spread/Supp. | +8.39% | +8.39% | -0.00% |
| Support | 5.48 | 5.48 | 5.94 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SPRY Stock
- Charts ARS Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
